[smartslider3 slider="2"]

Pharma D-mand's helped connect our content with the right audience, gather meaningful feedback, and develop new relationships

October 22nd, 2024 – 4pm (CET) / 10am (ET)

Join our webinar to navigate the complexities of clinical studies for Orally Inhaled and Nasal Drug Products (OINDPs). Learn how to balance preparation, mitigate risks in CMC studies, and collaborate with experts to optimise development and meet regulatory requirements

October 1st, 2024 – 4pm (CET) / 10am (ET)

Join us for an insightful webinar, Sharpening the Future – New Opportunities for Implant Injection. This session is perfect for healthcare professionals, industry experts, and anyone interested in the future of medical implants.

November 29th, 2023 - 4pm (CET) / 10am (ET)

Particles in the visible and subvisible size range can appear in (bio)pharmaceutical samples and drug products during all stages of development and even after market approval.

November 20th, 2024 – 4pm (CET) / 10am (ET)

In this webinar, Prof. Dr. Susumu Uchiyama will provide an overview of today’s state-of-the art analytical methods for AAV characterization and address key parameters to monitor during process development in AAV manufacturing.

November 14th, 2024 – 4pm (CET) / 10am (ET)

In this webinar, our speakers will be discussing the critical aspects of GMP Annex 1 Implementation. They will cover essential topics such as compliance and sterility assurance, flexible sterile capacity, and effective risk mitigation strategies.

May 8, 2024 - 11am (ET) / 10am (ET)

Unlock the full potential of Oral Solid Dosage (OSD) manufacturing by diving into the intricacies of capsules, packaging materials, and process equipment, overcoming formulation challenges, and mastering cost-effective scale-up processes.
Medidata blue logo

May 7, 2024 – 4pm (CET) / 10am (ET)

Dive into the critical realm of surfactants with our engaging webinar, shedding light on their significance in biologics and gene & cell therapy formulation development.

March 7, 2024 – 3pm (GMT) / 10am (ET)

Explore the nuances of capsules, packaging materials, and process equipment in OSD manufacturing. Overcome common OSD formulation challenges and gain insights into cost-effective scale-up processes.

June 27th, 2024 - 4pm (CET) / 10am (ET)

Discover the transformative journey of preservative-free spray systems in the pharmaceutical industry over three decades, delving into the benefits across pharmaceuticals, medical devices, and cosmetics, alongside a deep dive into regulatory landscapes like the EU’s MDR for drug-device combinations.

July 11th, 2024 – 4pm (CET) / 10am (ET)

In this webinar, Enrico Barichello, Product Manager for Syringe Platform in Stevanato Group and Alan Xu, Product Manager for Analytical Services in Stevanato Group, will be discussing the best strategy between customers and suppliers to select the right container based on the key features of the combination product.

July 10th, 2024 – 4pm (CET) / 10am (ET)

Discover advanced lyo modelling techniques to enhance freeze-drying processes and improve pharmaceutical product quality. Gain valuable insights from industry experts in this focused session.

February 27th, 2025 – 4pm (CET) / 10am (ET)

This webinar explores best practices for identifying and selecting the most developable lead candidates, defining the formulation corridor through robust pre-formulation screening, and incorporating clinical in-use stability testing to de-risk your strategy

February 26th 2025 – 3pm (GMT) / 10am (ET)

In this webinar, Dr. Ian Lafferty will explore practical approaches and proven techniques for refining formulations, managing Phase 1 outcomes, and optimising development timelines. Real-world examples bring clarity to these complex processes, enabling you to navigate common obstacles with confidence.

February 21st, 2024 - 4pm (CET) / 10am (ET)

This webinar will cover common issues during the development for different biologics drug product presentations. The experts will be highlighting how DP and Clinical Development are linked, going into detail about phase-appropriate actions taken as part of the roadmap.

April 8th 2025 – 4pm (CET) / 10am (ET)

Particulate and microbial contamination are major causes of FDA recalls, posing significant risks to patients. The European Medicine Agency updated Annex 1 of the Good Manufacturing Practices sets to tackle these considerations to improve patient safety, which is putting Pharma companies under pressure for implementing new processes and complying to these new standards.

April 10th, 2025 – 4pm (CET) / 10am (ET)

This webinar will explore the limitations of current drug delivery methods, focusing on challenges such as volume constraints, patient comfort, and adherence. Using the Sorrel OBDS platform as a case study, we will highlight its role in the development of the UDENYCA On-body injector.